← Back to homeCDC Finds Many GLP-1 Users Skip or Cut Their Doses
A new federal survey looks at how Americans actually take the popular diabetes and weight-loss drugs, and why many depart from their prescriptions.
Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources Brief
About 1 in 10 U.S. adults took a GLP-1 medication such as Ozempic, Wegovy or Zepbound in the past year, according to a…
More reporting and context continue here.
The complete story is available with Premium.
Read the facts, open questions and supporting sources.
Continue reading with NewsPlain Premium.
Keep reading with NewsPlain Premium
Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.
4 confirmed facts, 1 open question and 2 sources behind this story.
By NewsPlain Editorial Team · Published
About this story
We haven’t published a correction to this story.
How NewsPlain works ← Back to home